B-type natriuretic peptide measurement in heart failure

Daniel M. Spevack; Arthur Schwartzbard

doi:10.1002/clc.4960270903

B-type natriuretic peptide measurement in heart failure

Daniel M. Spevack, Arthur Schwartzbard

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

Original language	English (US)
Pages (from-to)	489-494
Number of pages	6
Journal	Clinical Cardiology
Volume	27
Issue number	9
DOIs	https://doi.org/10.1002/clc.4960270903
State	Published - Sep 2004
Externally published	Yes

Keywords

B-type natriuretic peptide
Diagnosis
Heart failure
Natriuretic
Prognosis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1002/clc.4960270903

Cite this

@article{117f5f7ca89549b1a1152b576fd5a2f7,

title = "B-type natriuretic peptide measurement in heart failure",

abstract = "Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.",

keywords = "B-type natriuretic peptide, Diagnosis, Heart failure, Natriuretic, Prognosis",

author = "Spevack, {Daniel M.} and Arthur Schwartzbard",

year = "2004",

month = sep,

doi = "10.1002/clc.4960270903",

language = "English (US)",

volume = "27",

pages = "489--494",

journal = "Clinical Cardiology",

issn = "0160-9289",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - B-type natriuretic peptide measurement in heart failure

AU - Spevack, Daniel M.

AU - Schwartzbard, Arthur

PY - 2004/9

Y1 - 2004/9

N2 - Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

AB - Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.

KW - B-type natriuretic peptide

KW - Diagnosis

KW - Heart failure

KW - Natriuretic

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=4344646920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344646920&partnerID=8YFLogxK

U2 - 10.1002/clc.4960270903

DO - 10.1002/clc.4960270903

M3 - Review article

C2 - 15471158

AN - SCOPUS:4344646920

SN - 0160-9289

VL - 27

SP - 489

EP - 494

JO - Clinical Cardiology

JF - Clinical Cardiology

IS - 9

ER -

B-type natriuretic peptide measurement in heart failure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this